news

Pfizer and Akili Join Forces For Gamification of Alzheimer’s Disease

Akili Interactive Labs Inc. announced today that it has entered into an agreement with Pfizer Inc. to test the ability of Akili's mobile video game platform ("Project EVO") to detect cognitive differences in healthy elderly people at risk of developing Alzheimer's disease. To Akili's knowledge this is the first time that a large pharmaceutical company [...]

January 6th, 2017|News|

Medtronic and FitBit Team Up To Improve Type 2 Diabetes Monitoring

Medtronic plc, the global leader in medical technology, and Fitbit, the leader in the connected health and fitness market, announced a partnership to integrate health and activity tracking for patients living with diabetes and their physicians and care teams. The iPro™2 myLog mobile app will allow patients to see their glucose levels and physical activity [...]

January 6th, 2017|News|

Insulog, an Innovative Insulin Tracker

Insulog, a device that connects with all major disposable insulin pen brands to display most recent injection data, paired with its app to display entire injection history in order to better manage diabetes, is today announcing the unveiling of its smart, connected insulin tracker. The device will soon be made available via Indiegogo, to bring [...]

January 6th, 2017|News|

Gamification, the next level of healthcare?

What is gamification? It’s more than likely that you’ve heard the word “gamification” thrown around in recent years, and if you’re not sure what it is then here's a quick definition. Gamification is the idea of turning usually ordinary and mundane tasks and instead making them more interactive and fun to complete, through the use of [...]

September 15th, 2016|Articles|

Google Life Sciences becomes Verily

Following the recent founding of the US-based conglomerate Alphabet Inc – a.k.a. the parent company to Google – in October, 2015, its research organisation, Google Life Sciences, has now been rebranded as Verily, a synonym of ‘truly’ or ‘certainly’. The name change is part of the company’s strategy to “reveal a true picture of health [...]

December 22nd, 2015|News|

AbbVie and Calico in 500M USD anti-aging deal

Google’s new company Calico, recently set up to tackle age-related diseases, have forged a deal with US pharmaceutical company AbbVie, in which both parties will invest $250M to create Calico research facilities and collaborate on the research, discovery and development of new medicines. The deal, announced Wednesday 3rd September, 2014, aims to aid Calico in [...]

September 10th, 2014|News|

Sony investment in Olympus expected to close this week

Months after announcing plans to seek a serious capital infusion, Japan's Olympus ($OCPNY) appears to have chosen Sony ($SNE) as the suitor suited for the task. Reuters reports that the company is expected to sign off on investing about 50 billion yen ($642 million) into the world's largest endoscope maker (also known for its cameras). [...]

September 26th, 2012|News|

FDA approves OraSure’s at-home HIV test

OraQuick is an at-home HIV test - a version of the company's lab-based diagnostic, and, using an oral swab, it can detect antibodies of HIV-1 and HIV-2 in about 20 minutes, according to the company. Assuming the device sells for $40 a unit, it could bring in about $20 million in sales by next year, [...]

July 13th, 2012|News|

Boston Scientific Begins U.S. and International Launch of WallFlex Stent System (WallFlex Biliary Transhepatic)

"We are very excited that the WallFlex Stent technology, originally designed for gastroenterologists, is now available for interventional radiologists and the patients we typically treat through percutaneous procedures," said Kelvin Hong, M.D., Johns Hopkins University, Baltimore, Maryland. "The WallFlex Biliary Transhepatic Stent System offers the latest advances in self-expanding metal stent technology with a delivery [...]

April 2nd, 2012|News|

Sanofi to Acquire Pluromed, Inc., Expanding Its Presence in Biosurgery

Sanofi and Pluromed Inc. announced today that they have entered into a definitive agreement under which Sanofi is to acquire Pluromed Inc., a medical device company based in Woburn, Massachusetts. The acquisition is subject to customary closing conditions. Pluromed has developed a proprietary polymer technology, called Rapid Transition Polymers (RTP(TM)), pioneering the use of injectable [...]

March 19th, 2012|News|